Hope has a way of quietly appearing when we least expect it

Since writing my last column, I’ve been struggling to find hope after being denied participation in a gene therapy clinical trial.

That may seem strange coming from me, since most of my writing over the years has been about the stubborn kind of hope that people living with Friedreich’s ataxia (FA) learn to carry, especially when the path ahead is uncertain. But part of me was simply tired of hoping.

People living with FA are quite cautious about hope. Often, it can feel like a mirage, appearing in clinical trial announcements, promising headlines, and emails you wait months to receive. When those things fall through, what remains is hollowness.

At times, a certain question lingers: How could I have been foolish enough to hope in the first place?

Recommended Reading

April 16, 2026 News by Agata Boxe

AAC 2026: How social media led to an FA diagnosis, and patient advocacy

For about a month, I’ve been living in that quiet place. I honestly believed the clinical trial might reshape my future. I planned so fully to be in it that even after I was denied, part of me was afraid to look toward a future without it.

So that’s where I’ve been this past month.

But something unexpected challenged that feeling. Actually, two things. One came from the world of science, and the other from a TV series that first aired when I was in high school.

‘I’m no Superman’

The first was the news that, following feedback from the U.S. Food and Drug Administration, Larimar Therapeutics is on track to submit an application seeking accelerated approval of nomlabofusp, its investigational protein replacement therapy for FA.

For most of my life, I simply haven’t had much to look forward to in terms of treatments. Research moved slowly, and the horizon felt distant. But nomlabofusp is different from previous potential treatments, because rather than addressing only FA symptoms, it targets the underlying cause of the disease. (For more details on the science behind it, see additional coverage in Friedreich’s Ataxia News.)

If development continues as expected, the treatment could become available as soon as next year. Living with FA has taught me not to assume that any therapy will solve everything. Still, it’s impossible to ignore what it means to finally have something tangible on the horizon.

I’ll even forgive people for the name “nomlabofusp,” which sounds less like a therapy and more like something the wizards in Dungeons & Dragons would prefer not to talk about.

The second thing that surprised me recently was the return of the TV series “Scrubs.”

That show has always symbolized hope to me. What made it special wasn’t just the humor, though there was plenty of that. It was the way it blended comedy with genuine empathy. One moment things could be completely ridiculous, and the next the show would quietly remind you how fragile and meaningful life really is.

The theme song includes the lyric “I’m no Superman,” which is one of the reasons the series resonated with me. It never pretended that people are invincible. Its characters made mistakes, struggled, and doubted themselves. But they kept showing up anyway.

Looking back, I realize that balance has shaped how I try to approach the world, with humor when I can find it, empathy when it matters most, and a willingness to keep going when things feel uncertain.

Larimar’s news represents the steady progress of science and the possibility that treatments for FA are finally getting closer to becoming a reality. “Scrubs” reminds me of the humanity that helps people endure difficult seasons of life.

Neither of these erases the challenges that come with FA or guarantees what the future will look like. But together they reminded me of something I’d forgotten: that hope doesn’t always return dramatically. Sometimes it slips quietly back into your life, through a research update or a familiar show that means a lot.

That quiet return doesn’t erase the disappointment I felt this year. But it does remind me that looking forward is still possible.

Note: Friedreich’s Ataxia News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Friedreich’s Ataxia News or its parent company, Bionews, and are intended to spark discussion about issues pertaining to Friedreich’s ataxia.